NASA's SpaceX Crew-11 Safely Returns to Earth
Digest more
Starlust on MSN
Controlled experiment allowed viruses to attack bacteria in space—and the results surprised scientists
The viruses devise ploys to break into bacterial defenses. Bacteria, on the other hand, strengthen their defenses so that they can easily thwart viral attacks. To find out how microgravity influences these battles,
Scientists discover microgravity in space could help fight drug-resistant superbugs by creating unique viral mutations, according to a new study.
For more than 25 years, humans have lived and worked continuously aboard the International Space Station, conducting research that is transforming life on Earth and shaping the future of exploration.
ISS research over 25 years shows how humans adapt biologically, medically, and technologically to space, informing future missions and scientific understanding of life beyond Earth.
A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests could have quickly formed in the presence of compounds called borates.
Viruses that infect bacteria can still do their job in microgravity, but space changes the rules of the fight.
The International Space Station (ISS) is one of the most unique environments where life has ever existed, out in the low orbit of Earth. And research out today finds that bacteriophages—the viruses that prey on bacteria—can behave quite peculiarly in space.
Space.com on MSN
Viruses may be more powerful in the International Space Station's microgravity environment
The International Space Station (ISS) is a closed ecosystem, and the biology inside it — including its microbial residents — don't necessarily behave the same way on our home planet.
Now that NASA has found evidence of water on Mars, astronauts will test the growth of a small plant in Martian soil, thanks to students at Bellevue’s Open Window School. The experiment will be one of 21 trials put to the test 250 miles above sea level on ...
Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving life for cancer patients worldwide.